has been cited by the following article(s):
|
[1]
|
LRP5 Down‐Regulation Exacerbates Inflammation and Alveolar Bone Loss in Periodontitis by Inhibiting PI3K/c‐FOS Signalling
Journal of Clinical Periodontology,
2025
DOI:10.1111/jcpe.14112
|
|
|
|
|
[2]
|
The Effect of Sclerostin and Monoclonal Sclerostin Antibody Romosozumab on Osteogenesis and Osteoclastogenesis Mediated by Periodontal Ligament Fibroblasts
International Journal of Molecular Sciences,
2023
DOI:10.3390/ijms24087574
|
|
|
|